Nanobody targets TNF and IL-6 for additive efficacy
- PMID: 36894778
- DOI: 10.1038/s41584-023-00947-z
Nanobody targets TNF and IL-6 for additive efficacy
Comment on
-
Additive efficacy of a bispecific anti-TNF/IL-6 nanobody compound in translational models of rheumatoid arthritis.Sci Transl Med. 2023 Feb;15(681):eabq4419. doi: 10.1126/scitranslmed.abq4419. Epub 2023 Feb 1. Sci Transl Med. 2023. PMID: 36724239
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
